<DOC>
	<DOCNO>NCT01112735</DOCNO>
	<brief_summary>The purpose study compare safety efficacy ARTISS versus standard care adhere tissue place reduce seroma/hematoma formation subject undergo abdominoplasty .</brief_summary>
	<brief_title>Efficacy Safety ARTISS Flap Adherence Abdominoplasty</brief_title>
	<detailed_description />
	<mesh_term>Hematoma</mesh_term>
	<mesh_term>Seroma</mesh_term>
	<mesh_term>Fibrin Tissue Adhesive</mesh_term>
	<criteria>Subject 18 75 year age time screen Subject plan primary standard abdominoplasty ( status post Cesarean section liposuction perform 6 month prior enrollment study allow ) If subject childbearing potential ; present negative pregnancy test , agree employ adequate birth control measure duration study Subject reside within 100 mile investigational site willing able comply schedule requirement protocol ( notably home visit study personnel ) Subject willing able comply requirement protocol Subject obese ( body mass index [ BMI ] &gt; 30 surgery ) Subject experience massive weight loss ( subject history obesity adult life ; subject lose 20 BMI unit score , subject undergone bariatric surgery ) Subject history active smoking within previous 12 month Subject elect nonstandard abdominoplasty ( extend , limited miniabdominoplasty , endoscopic , fleurdelis circumferential abdominoplasty ) panniculectomy Subject scar abdominal wall umbilicus . Vertical midline , laparoscopic puncture , liposuction puncture permit Subject plan `` body lift '' procedure ( eg arm , leg , back etc . ) Subject plan combine abdominoplasty cosmetic procedure include liposuction ( restrict liposuction waist line low back allow , long integrity surgical space maintain ) Subject active chronic skin disorder , history evidence keloid formation , hypertrophic scar Subject history gastrointestinal disorder ( eg Irritable Bowel Syndrome ) require prescription medication Subject know abdominal hernia require mesh fixation Subject document hiatal hernia acid reflux disease Subjects congenital acquire immunodeficiency disorder Subject uncontrolled diabetes mellitus ( HbA1c &gt; 7.0 ) Subject history cardiovascular disease include uncontrolled hypertension ( &gt; 140/90 mm Hg ) Subject clinically diagnose psychiatric disorder ( include obsessive compulsive disorder ) Subject know ( document ) bleed coagulation disorder include history thromboembolic event Subject treat anticoagulant Aspirin ( discontinue 7 day prior surgery ) Subject receive active treatment malignancy Subject connective tissue disorder Subject receive chronic treatment immunosuppressive drug , systemic corticosteroid , chronic treatment within 30 day prior surgery Subject participate another clinical study involve investigational product ( IP ) investigational device within 30 day prior enrollment schedule participate another clinical study involve IP investigational device course study Subject know sensitivity fibrin sealant Subject friend , employee , relative investigator study personnel</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Abdominoplasty</keyword>
	<keyword>Flap adherence subject undergo abdominoplasty eliminate dead space reduce seroma/hematoma formation</keyword>
</DOC>